A detailed history of Td Asset Management Inc transactions in Dexcom Inc stock. As of the latest transaction made, Td Asset Management Inc holds 230,680 shares of DXCM stock, worth $17.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
230,680
Previous 276,948 16.71%
Holding current value
$17.2 Million
Previous $31.4 Million 50.76%
% of portfolio
0.01%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$64.0 - $116.06 $2.96 Million - $5.37 Million
-46,268 Reduced 16.71%
230,680 $15.5 Million
Q2 2024

Aug 02, 2024

SELL
$110.31 - $140.45 $672,449 - $856,183
-6,096 Reduced 2.15%
276,948 $31.4 Million
Q1 2024

May 08, 2024

SELL
$114.22 - $140.1 $1.7 Million - $2.08 Million
-14,875 Reduced 4.99%
283,044 $39.3 Million
Q4 2023

Feb 12, 2024

BUY
$75.49 - $124.16 $1.57 Million - $2.58 Million
20,757 Added 7.49%
297,919 $37 Million
Q3 2023

Oct 27, 2023

BUY
$86.06 - $137.93 $4.12 Million - $6.6 Million
47,876 Added 20.88%
277,162 $25.9 Million
Q2 2023

Aug 09, 2023

SELL
$112.47 - $130.98 $1.98 Million - $2.31 Million
-17,645 Reduced 7.15%
229,286 $29.5 Million
Q1 2023

May 10, 2023

BUY
$104.0 - $122.92 $129,064 - $152,543
1,241 Added 0.51%
246,931 $28.7 Million
Q4 2022

Feb 06, 2023

BUY
$84.98 - $122.67 $293,435 - $423,579
3,453 Added 1.43%
245,690 $27.8 Million
Q3 2022

Nov 07, 2022

SELL
$76.35 - $94.18 $17,484 - $21,567
-229 Reduced 0.09%
242,237 $19.9 Million
Q2 2022

Aug 04, 2022

BUY
$67.99 - $132.89 $12.3 Million - $24.1 Million
181,349 Added 296.72%
242,466 $18.1 Million
Q1 2022

May 10, 2022

SELL
$94.08 - $130.2 $9,219 - $12,759
-98 Reduced 0.16%
61,117 $31.3 Million
Q4 2021

Feb 10, 2022

SELL
$129.87 - $162.82 $259,220 - $324,988
-1,996 Reduced 3.16%
61,215 $32.9 Million
Q3 2021

Nov 09, 2021

SELL
$106.71 - $143.18 $95,612 - $128,289
-896 Reduced 1.4%
63,211 $34.6 Million
Q2 2021

Aug 11, 2021

BUY
$80.99 - $107.93 $43,653 - $58,174
539 Added 0.85%
64,107 $33 Million
Q1 2021

May 14, 2021

SELL
$84.79 - $104.74 $461,681 - $570,309
-5,445 Reduced 7.89%
63,568 $22.8 Million
Q4 2020

Feb 16, 2021

BUY
$78.0 - $104.5 $360,750 - $483,312
4,625 Added 7.18%
69,013 $25.5 Million
Q3 2020

Nov 10, 2020

BUY
$95.51 - $112.95 $1.05 Million - $1.24 Million
10,991 Added 20.58%
64,388 $26.5 Million
Q2 2020

Aug 13, 2020

BUY
$62.68 - $105.34 $1.15 Million - $1.93 Million
18,369 Added 52.44%
53,397 $21.6 Million
Q1 2020

May 15, 2020

SELL
$47.79 - $75.63 $224,613 - $355,461
-4,700 Reduced 11.83%
35,028 $9.43 Million
Q4 2019

Feb 11, 2020

SELL
$36.62 - $57.29 $166,328 - $260,211
-4,542 Reduced 10.26%
39,728 $8.69 Million
Q3 2019

Nov 07, 2019

BUY
$35.53 - $43.8 $62,177 - $76,650
1,750 Added 4.12%
44,270 $6.61 Million
Q2 2019

Aug 01, 2019

BUY
$27.84 - $38.92 $429,960 - $601,080
15,444 Added 57.04%
42,520 $6.37 Million
Q1 2019

May 08, 2019

BUY
$28.07 - $38.18 $410,074 - $557,771
14,609 Added 117.18%
27,076 $3.23 Million
Q4 2018

Feb 01, 2019

SELL
$26.99 - $37.37 $1.59 Million - $2.2 Million
-58,806 Reduced 82.51%
12,467 $1.49 Million
Q3 2018

Nov 01, 2018

SELL
$23.35 - $36.72 $191,470 - $301,104
-8,200 Reduced 10.32%
71,273 $10.2 Million
Q2 2018

Jul 31, 2018

SELL
$17.54 - $25.22 $611,111 - $878,690
-34,841 Reduced 30.48%
79,473 $7.55 Million
Q1 2018

May 11, 2018

BUY
$13.06 - $18.54 $37,874 - $53,766
2,900 Added 2.6%
114,314 $8.48 Million
Q4 2017

Feb 02, 2018

BUY
$11.12 - $15.38 $835,779 - $1.16 Million
75,160 Added 207.32%
111,414 $6.39 Million
Q3 2017

Nov 09, 2017

BUY
$11.36 - $18.98 $411,845 - $688,100
36,254
36,254 $1.77 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $28.8B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.